<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27737408</article-id><article-id pub-id-type="pmc">5062708</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160048</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Mild Hypothermia May Offer Some Improvement to Patients with MODS
after CPB Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Xiaoqi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Tianxiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Xiu</surname><given-names>Zongyi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Enyi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><aff id="aff1"><label>1</label>Department of Cardiac Surgery ICU, The First Affiliated Hospital
of China Medical University, Shenyang, P.R. China</aff></contrib-group><author-notes><corresp id="c1"><bold>Correspondence Address:</bold> Xiaoqi Zhao, Nanjingbei Street
155 Heping Shenyang District, People's Republic of China. E-mail:
<email>cmuzxq@uw.edu</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2016</year></pub-date><volume>31</volume><issue>3</issue><fpage>246</fpage><lpage>251</lpage><history><date date-type="received"><day>05</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>08</day><month>6</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>OBJECTIVE:</title><p>To summarize the effect of mild hypothermia on function of the organs in
patients with multiple organ dysfunction syndrome after cardiopulmonary
bypass surgery.</p></sec><sec><title>METHODS:</title><p>The patients were randomly divided into two groups, northermia group (n=71)
and hypothermia group (n=89). We immediately began cooling the hypothermia
group when test results showed multiple organ dysfunction syndrome,
meanwhile all patients of two groups were drawn blood to test blood gas,
liver and kidney function, blood coagulation function, and evaluated the
cardiac function using echocardiography from 12 to 36 hours. We compared the
difference of intra-aortic balloon pump, extracorporeal membrane oxygenation
rate and mortality within one month after intensive care unit admission.</p></sec><sec><title>RESULTS:</title><p>Among the 160 patients, 36 died, 10 (11.24%) patients were from the
hypothermia group and 26 (36.6%) from the northermia group
(<italic>P</italic> &#x0003c;0.05). In northermia group, 45 (63.38%) patients
used intra-aortic balloon pump and 4 (5.63%), extracorporeal membrane
oxygenation; in hypothermia group, 35 (39.32%) patients used intra-aortic
balloon pump and 2 (2.25%), extracorporeal membrane oxygenation&#x0ff08;
<italic>P</italic> &#x0003c;0.05). The patients' heart rate decreased
significantly in the hypothermia group. The heart rate of hypothermia group
is significantly slower than the northermia group at the 36<sup>th</sup>
hour (<italic>P</italic> &#x0003c;0.05). But the mean arterial pressure of
hypothermia group is significantly higher than the northermia group at the
36<sup>th</sup> hour (<italic>P</italic> &#x0003c;0.05). In hypothermia
group, PO<sub>2</sub>, SvO<sub>2</sub> and lactate were improved
significantly compared to pre-cooling (<italic>P</italic> &#x0003c;0.05), and
they were significantly better than the northermia group at the
36<sup>th</sup> hour (<italic>P</italic> &#x0003c;0.05%). Prothrombin time
and activated partial thromboplastin time have no significantly difference
between the two groups (<italic>P</italic> &#x0003e;0.05). But the platelet count
has significantly difference between the two groups at the 36<sup>th</sup>
hour (<italic>P</italic> &#x0003c;0.05). The aspartate transaminase, alanine
transaminase and creatinine were improved significantly in the hypothermia
group, and they were significantly better than the northermia group
(<italic>P</italic> &#x0003c;0.05).</p></sec><sec><title>CONCLUSION:</title><p>Mild hypothermia is feasible and safe for patients with multiple organ
dysfunction syndrome after cardiopulmonary bypass surgery.</p></sec></abstract><kwd-group><kwd>Hypothermia</kwd><kwd>Multiple Organ Failure</kwd><kwd>Shock</kwd><kwd>Cardiogenic</kwd></kwd-group></article-meta></front><body><p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Abbreviations, acronyms &#x00026;
symbols</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">ALB</td><td rowspan="1" colspan="1">= Albumin</td></tr><tr><td rowspan="1" colspan="1">ALT</td><td rowspan="1" colspan="1">= Alanine transaminase</td></tr><tr><td rowspan="1" colspan="1">APTT</td><td rowspan="1" colspan="1">= Activated partial thromboplastin time</td></tr><tr><td rowspan="1" colspan="1">AST</td><td rowspan="1" colspan="1">= Aspartate transaminase</td></tr><tr><td rowspan="1" colspan="1">ATP</td><td rowspan="1" colspan="1">= Adenosine triphosphate</td></tr><tr><td rowspan="1" colspan="1">BSA</td><td rowspan="1" colspan="1">= Body surface area</td></tr><tr><td rowspan="1" colspan="1">CI</td><td rowspan="1" colspan="1">= Cardiac index</td></tr><tr><td rowspan="1" colspan="1">CPB</td><td rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td rowspan="1" colspan="1">ECMO</td><td rowspan="1" colspan="1">= Extracorporeal membrane oxygenation</td></tr><tr><td rowspan="1" colspan="1">Emax</td><td rowspan="1" colspan="1">= Ventricular end-systolic maximum elastance</td></tr><tr><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">= Heart rate</td></tr><tr><td rowspan="1" colspan="1">HT</td><td rowspan="1" colspan="1">= Hypothermia group</td></tr><tr><td rowspan="1" colspan="1">IABP</td><td rowspan="1" colspan="1">= Intra-aortic balloon pump</td></tr><tr><td rowspan="1" colspan="1">ICU</td><td rowspan="1" colspan="1">= Intensive Care Unit</td></tr><tr><td rowspan="1" colspan="1">LCOS</td><td rowspan="1" colspan="1">= Low cardiac output syndrome</td></tr><tr><td rowspan="1" colspan="1">MAP</td><td rowspan="1" colspan="1">= Mean arterial pressure</td></tr><tr><td rowspan="1" colspan="1">MODS</td><td rowspan="1" colspan="1">= Multiple organ dysfunction syndrome</td></tr><tr><td rowspan="1" colspan="1">NT</td><td rowspan="1" colspan="1">= Northermia group</td></tr><tr><td rowspan="1" colspan="1">PLT</td><td rowspan="1" colspan="1">= Platelet count</td></tr><tr><td rowspan="1" colspan="1">PT</td><td rowspan="1" colspan="1">= Prothrombin time</td></tr><tr><td rowspan="1" colspan="1">PVA</td><td rowspan="1" colspan="1">= Pressure-volume area</td></tr><tr><td rowspan="1" colspan="1">SIRS</td><td rowspan="1" colspan="1">= Systemic inflammatory response syndrome</td></tr><tr><td rowspan="1" colspan="1">SV</td><td rowspan="1" colspan="1">= Stroke volume</td></tr></tbody></table></table-wrap>
</p><sec sec-type="intro"><title>INTRODUCTION</title><p>Multiple organ dysfunction syndrome (MODS) is defined as "the presence of altered
organ function in an acutely ill patient such that homeostasis cannot be maintained
with intervention"<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. It is a
cause of high mortality and morbidity in Intensive Care Unit (ICU)<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Many advances have been made in
the treatment of MODS. Hypothermia has become an established therapeutic concept in
the treatment of cardiovascular and neurological diseases<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and it has shown myocardial and neurological
protection, yet the benefits for MODS after cardiac surgery have not been well
defined. We hypothesized that mild hypothermia has organ protective effects and can
ameliorate organ dysfunction to improve the survival rate for the patients with MODS
after cardiopulmonary bypass (CPB) cardiac surgery.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Design</title><p>The study was designed as prospective unblended intervention trial where patients
served as their own controls. This study protocol was approved by the ethics
committee of the First Affiliated Hospital of China Medical University. The
patients with MODS after cardiac surgery underdoing CPB from May 2011 to
February 2015 were screened for this study. The cardiac function of all the
patients was class II-III (New York Heart Association).</p><p>Exclusion criteria: patients with respiratory, nervous, hematological system
diseases or liver, kidney, digestive system diseases before surgery; patients
with massive blood transfusion (massive blood transfusion defined as the
replacement of a patients' total blood volume in less than 24 hours, or as the
acute administration more than half the patients' estimated blood volume per
hour); patients died within 24 hours after ICU admission.</p><p>The MODS diagnosis criterion of MODS<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> is shown in <xref ref-type="table" rid="t1">Table
1</xref>.</p><p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>The diagnostic criteria of MODS<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><colgroup span="1"><col width="15%" span="1"/><col width="65%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><bold>System</bold></th><th colspan="2" align="center" rowspan="1"><bold>Criterion</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Circulatory</td><td align="center" rowspan="1" colspan="1">(1) SBP &#x0003c;90 mmHg;<break/> (2) MAP &#x0003c;70
mmHg;<break/> (3) shock, ventricular tachycardia or
ventricular fibrillation, myocardial infarction</td><td align="center" rowspan="1" colspan="1">Any of the three</td></tr><tr><td rowspan="1" colspan="1">Respiratory</td><td align="center" rowspan="1" colspan="1">Oxygenation index (PO/FiO<sub>2</sub>)
&#x0003c;300 mmHg</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Nervous</td><td align="center" rowspan="1" colspan="1">(1) Indifference or agitation, drowsiness,
coma<break/> (2) Glasgow score &#x02264; 14</td><td align="center" rowspan="1" colspan="1">Any of the two</td></tr><tr><td rowspan="1" colspan="1">Blood</td><td align="center" rowspan="1" colspan="1">(1) PLT&#x0003c;100*10<sup>9</sup>/L<break/> (2)
TT, APTT Prolonged or shortened PT,3P(+)</td><td align="center" rowspan="1" colspan="1">Any of the two</td></tr><tr><td rowspan="1" colspan="1">Liver</td><td align="center" rowspan="1" colspan="1">(1) TBIL &#x0003e;20.5 &#x000b5;mol/L<break/> (2)
ALB &#x0003c;28 g/L;</td><td align="center" rowspan="1" colspan="1">Any of the two</td></tr><tr><td rowspan="1" colspan="1">Urinary system</td><td align="center" rowspan="1" colspan="1">(1) blood Cr&#x0003e;123.8 &#x000b5;mol/L;<break/>
(2) urine volume &#x0003c; 500 ml/24h.</td><td align="center" rowspan="1" colspan="1">Any of the two</td></tr><tr><td rowspan="1" colspan="1">Gastrointestinal</td><td align="center" rowspan="1" colspan="1">(1) bowel sounds weaken or disappear;<break/>
(2) gastric drainage fluid or stool occult blood (+), or
black stool, haematemesis.<break/> (3) intra-abdominal
pressure &#x02265; 11 cmH<sub>2</sub>O.</td><td align="center" rowspan="1" colspan="1">Any of the three</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ALB=albumin; APTT=activated partial thromboplastin time;
Cr=creatinine; MAP=mean arterial pressure; PLT=platelet count;
PT=prothrombin time; SBP=systolic blood pressure; TBIL=total
bilirubin; TT=thrombin time</p></fn></table-wrap-foot></table-wrap>
</p><p>All the patients used urine catheter with temperature probe by which we can
monitore the patients' bladder temperature. At the admission to Cardiac Surgery
ICU, the patients were assisted by ventilator, tidal volume (ml) = Body weight
(kg)*10(ml/kg); respiratory frequency 12-14 times/min;
FiO<sub>2</sub>:0.50-0.75. At the same time, intravenous sedation and muscular
relaxation agent were infused. We used the echocardiography to monitor cardiac
stroke volume (SV), then we calculated cardiac index (CI), CI=heart rate
(HR)*SV/body surface area (BSA).</p><p>The basic treatments for the patients of the two groups are same, including
intravenous infusion of vasoactive agents to maintain hemodynamic stability and
improve organs function. However, in the hypothermia group (HT), hypothermia
treatment was implemented by a computer cooling blanket (CJ1 temperature
lowering instrument). The patient was placed on the blanket which is filled with
the variable temperature cycle of cryogenic mat. We adjusted the temperature of
cooling blanket until the patients' bladder temperature reached and maintained
35&#x000ba;C. The cooling rate was about 1.0&#x000ba;C/h<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. The bladder temperature was reduced from
36.1&#x000ba;C&#x000b1;0.2&#x000ba;C to 33.1&#x000ba;C&#x000b1;0.1&#x000ba;C within 168&#x000b1;10min of starting
cooling and remained lowered at 32.9&#x000b1;0.5&#x000ba;C during 36 hours.</p></sec><sec><title>Data Collection</title><p>If patients' postoperative test results (we marked it as precooling) showed two
or more abnormal organ function, we considered the existence of MODS. The
patients were randomly divided into two groups, one is northermia group (NT)
n=71, the other one is HT (hypothermia group) n=89. Then we immediately began
cooling the HT (we marked the time as 0h), meanwhile all patients were drawn
arterial blood and venous blood to test blood gas, liver and kidney function,
blood coagulation function, and evaluated the cardiac function using
echocardiography from 12 to 36 hours. We monitored each patient closely about
the parameters of vital signs: mean arterial pressure (MAP), HR, urinary
volume.</p></sec><sec><title>Statistical Analysis</title><p>All statistical analysis were performed using SPSS 17.0, measurement data of each
group were performed using normality test, F-test and tested with Rank test.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Among the 160 patients considered for inclusion, 36 died, 10 (11.24%) patients were
from the HT and 26 (36.6%) were from the NT (<italic>P</italic> &#x0003c;0.05). In NT,
there were 45 patients who used IABP = Intra-aortic balloon pump (63.38%), 4
patients who used extracorporeal membrane oxygenation (ECMO) (5.63%). In HT, there
were 35 patients who used IABP (39.32%), 2 (2.25%) patients ECMO (<italic>P</italic>
&#x0003c;0.05). The patients' HR decreased significantly after the application of
hypothermia. The HR difference between the two groups at the 36<sup>th</sup> hour is
significant (<italic>P</italic> &#x0003c;0.05), shown as <xref ref-type="fig" rid="f1">Figure 1</xref>. The MAP of HT is lower than NT significantly at 0 hour,
because we used the sedation and muscular relaxation agent, and the depth of
sedation in HT is much more deeply than NT in order to prevent chill. But the MAP of
HT is significantly higher than NT after hypothermia at the 36<sup>th</sup> hour
(<italic>P</italic> &#x0003c;0.05), shown as <xref ref-type="fig" rid="f2">Figure
2</xref>. PO<sub>2</sub>, SvO<sub>2</sub>, lactate and CI have no significantly
difference between the two groups pre-cooling (<italic>P</italic> &#x0003e;0.05). In HT
group, PO<sub>2</sub>, SvO<sub>2</sub> and lactate were improved significantly at
the 36<sup>th</sup> hour compared with pre-cooling (<italic>P</italic> &#x0003c;0.05),
and they were better than NT group significantly at the 36<sup>th</sup> hour
(<italic>P</italic> &#x0003c;0.05%) as shown in <xref ref-type="table" rid="t2">Table
2</xref>. Prothrombin time (PT) and activated partial thromboplastin time (APTT)
have no significantly difference between the two groups (<italic>P</italic>
&#x0003e;0.05). But the platelet count (PLT) has significantly difference between the two
groups at the 36<sup>th</sup> hour (<italic>P</italic> &#x0003c;0.05%), shown in <xref ref-type="table" rid="t3">Table 3</xref>. The aspartate transaminase (AST),
alanine transaminase (ALT) and creatinine were improved significantly in the HT
group, and they were significantly better than the NT group (<italic>P</italic>
&#x0003c;0.05), shown in <xref ref-type="table" rid="t4">Table 4</xref>.</p><p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Changes of blood gas and CI.</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><colgroup span="1"><col width="16%" span="1"/><col width="12%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="12%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1"><bold>Variables</bold></th><th colspan="4" align="center" rowspan="1"><bold>HT (n=89)</bold></th><th colspan="4" align="center" rowspan="1"><bold>NT (n=71)</bold></th></tr><tr><th align="center" rowspan="1" colspan="1">pre-cooling</th><th align="center" rowspan="1" colspan="1">12h</th><th align="center" rowspan="1" colspan="1">24h</th><th align="center" rowspan="1" colspan="1">36h</th><th align="center" rowspan="1" colspan="1">pre-cooling</th><th align="center" rowspan="1" colspan="1">12h</th><th align="center" rowspan="1" colspan="1">24h</th><th align="center" rowspan="1" colspan="1">36h</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">PO<sub>2</sub> (mmHg)</td><td align="center" rowspan="1" colspan="1">88&#x000b1;13</td><td align="center" rowspan="1" colspan="1">89&#x000b1;17</td><td align="center" rowspan="1" colspan="1">95&#x000b1;9</td><td align="center" rowspan="1" colspan="1">102&#x000b1;11<xref ref-type="table-fn" rid="TFN3">#</xref><xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">85&#x000b1;15</td><td align="center" rowspan="1" colspan="1">88&#x000b1;10</td><td align="center" rowspan="1" colspan="1">90&#x000b1;12</td><td align="center" rowspan="1" colspan="1">89&#x000b1;14</td></tr><tr><td rowspan="1" colspan="1">SvO<sub>2</sub> (%)</td><td align="center" rowspan="1" colspan="1">41&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">44&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">50&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">53&#x000b1;1.1<xref ref-type="table-fn" rid="TFN3">#</xref><xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">43&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">42&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">45&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">48&#x000b1;1.7</td></tr><tr><td rowspan="1" colspan="1">Lac (mmol/L)</td><td align="center" rowspan="1" colspan="1">8.2&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">8.9&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">8.0&#x000b1;1.1</td><td align="center" rowspan="1" colspan="1">5.5&#x000b1;1.5<xref ref-type="table-fn" rid="TFN3">#</xref><xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">7.9&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">8.5&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">8.2&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">8.1&#x000b1;1.8</td></tr><tr><td rowspan="1" colspan="1">CI (ml.m<sup>-1</sup>.m<sup>-2</sup>)</td><td align="center" rowspan="1" colspan="1">30&#x000b1;5.0</td><td align="center" rowspan="1" colspan="1">34&#x000b1;4.6</td><td align="center" rowspan="1" colspan="1">37&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">42&#x000b1;5.0<xref ref-type="table-fn" rid="TFN3">#</xref><xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">30.2&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">32&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">31&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">34&#x000b1;2.8</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>#</label><p><italic>P</italic>&#x0003c;0.05 <italic>versus</italic> pre-cooling;</p></fn><fn id="TFN3"><label>*</label><p><italic>P</italic>&#x0003c;0.05 <italic>versus</italic> NT</p></fn><fn id="TFN4"><p>CI=cardiac index; Lac=lactate</p></fn></table-wrap-foot></table-wrap>
</p><p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Coagulation index changes.</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><colgroup span="1"><col width="16%" span="1"/><col width="12%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="12%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1"><bold>Variables</bold></th><th colspan="4" align="center" rowspan="1"><bold>HT (n=89)</bold></th><th colspan="4" align="center" rowspan="1"><bold>NT (n=71)</bold></th></tr><tr><th align="center" rowspan="1" colspan="1">pre-cooling</th><th align="center" rowspan="1" colspan="1">12h</th><th align="center" rowspan="1" colspan="1">24h</th><th align="center" rowspan="1" colspan="1">36h</th><th align="center" rowspan="1" colspan="1">pre-cooling</th><th align="center" rowspan="1" colspan="1">12h</th><th align="center" rowspan="1" colspan="1">24h</th><th align="center" rowspan="1" colspan="1">36h</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">PT(s)</td><td align="center" rowspan="1" colspan="1">16.0&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">15.9+3.9</td><td align="center" rowspan="1" colspan="1">15.0+2.6</td><td align="center" rowspan="1" colspan="1">14.4+3.5</td><td align="center" rowspan="1" colspan="1">14.5+3.1</td><td align="center" rowspan="1" colspan="1">13.6+1.6</td><td align="center" rowspan="1" colspan="1">13.4+2.1</td><td align="center" rowspan="1" colspan="1">13.6+1.9</td></tr><tr><td rowspan="1" colspan="1">APTT(s)</td><td align="center" rowspan="1" colspan="1">38.9&#x000b1;6.8</td><td align="center" rowspan="1" colspan="1">41.1+6.8</td><td align="center" rowspan="1" colspan="1">36.3+4.0</td><td align="center" rowspan="1" colspan="1">40.0+11.2</td><td align="center" rowspan="1" colspan="1">38.1+5.7</td><td align="center" rowspan="1" colspan="1">38.8+4.5</td><td align="center" rowspan="1" colspan="1">36.7+4.5</td><td align="center" rowspan="1" colspan="1">38.3+4.1</td></tr><tr><td rowspan="1" colspan="1">PLT</td><td align="center" rowspan="1" colspan="1">259+101</td><td align="center" rowspan="1" colspan="1">218+158</td><td align="center" rowspan="1" colspan="1">267+168</td><td align="center" rowspan="1" colspan="1">372+150<xref ref-type="table-fn" rid="TFN6">#</xref><xref ref-type="table-fn" rid="TFN7">*</xref></td><td align="center" rowspan="1" colspan="1">261+99</td><td align="center" rowspan="1" colspan="1">247+185</td><td align="center" rowspan="1" colspan="1">234+178</td><td align="center" rowspan="1" colspan="1">300+139</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>#</label><p>P&#x0003c;0.05 <italic>versus</italic> pre-cooling;</p></fn><fn id="TFN6"><label>*</label><p>P&#x0003c;0.05 <italic>versus</italic> NT.</p></fn><fn id="TFN7"><p>APTT=activated partial thromboplastin time; PLT=platelet count;
PT=prothrombin time</p></fn></table-wrap-foot></table-wrap>
</p><p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Liver and kidney index changes.</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" colspan="1"><bold>Variables</bold></th><th colspan="2" align="center" rowspan="1"><bold>HT (n=89)</bold></th><th colspan="2" align="center" rowspan="1"><bold>NT (n=71)</bold></th></tr><tr><th align="center" rowspan="1" colspan="1">pre-cooling</th><th align="center" rowspan="1" colspan="1">36h</th><th align="center" rowspan="1" colspan="1">pre-cooling</th><th align="center" rowspan="1" colspan="1">36h</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">rank (ALT)</td><td align="center" rowspan="1" colspan="1">341</td><td align="center" rowspan="1" colspan="1">257</td><td align="center" rowspan="1" colspan="1">321</td><td align="center" rowspan="1" colspan="1">398</td></tr><tr><td rowspan="1" colspan="1">rank (AST)</td><td align="center" rowspan="1" colspan="1">338</td><td align="center" rowspan="1" colspan="1">268.1</td><td align="center" rowspan="1" colspan="1">318</td><td align="center" rowspan="1" colspan="1">370.8</td></tr><tr><td rowspan="1" colspan="1">rank (Cr)</td><td align="center" rowspan="1" colspan="1">388</td><td align="center" rowspan="1" colspan="1">246.5</td><td align="center" rowspan="1" colspan="1">364</td><td align="center" rowspan="1" colspan="1">379.5</td></tr></tbody></table><table-wrap-foot><fn id="TFN8"><p>ALT=alanine transaminase; AST=aspartate transaminase;
Cr=creatinine</p></fn></table-wrap-foot></table-wrap>
</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Heart rate (HR) changes of the two groups. The patients&#x02019; heart rate
decreased significantly after the application of hypothermia. The HR
difference between two groups at the 36<sup>th</sup> hour is significant
(P&#x0003c;0.05).</p></caption><graphic xlink:href="rbccv-31-03-0246-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Mean arterial pressure (MAP) changes of the two groups. The MAP of the HT
is significantly lower than the NT at 0 hour, because we used the
sedation and neuromuscular blockade. But the MAP of the HT is
significantly higher than the NT after hypothermia at the
36<sup>th</sup> hour (P&#x0003c;0.05).</p></caption><graphic xlink:href="rbccv-31-03-0246-g02"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The first major finding of the present study is that the induction of mild
hypothermia until the 36<sup>th</sup> hour is feasible and safe for patients with
MODS after CPB. There are several proposed mechanisms for the development of MODS,
including<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>:(1) cell or
tissue hypoxia; (2) induction of cellular apoptosis; (3) translocation of microbes
or components of microbes from the gastrointestinal tract; (4) immune system
dysregulation, and (5) mitochondrial dysfunction. The predominant failure organs
involved in MODS are hepatic, respiratory, gastrointestinal, cardiovascular,
coagulation, renal, central nervous and endocrine systems<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Most cardiac surgery need CPB, but intra-operation
of cardiac surgery, CPB can lead to a variety of inflammatory medium content
increased significantly. As a result abnormal cytokine expression and systemic
inflammatory reaction in tissues impaired the organs function<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, and even lead to further multiple
organ dysfunction<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Hypothermia can be divided into mild hypothermia (32-35&#x000ba;C), moderate hypothermia
(28-32&#x000ba;C), deep hypothermia (20-28&#x000ba;C), super-deep hypothermia (&#x0003c;20&#x000ba;C)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Many studies have shown that
mild hypothermia interference with the body's homeostasis is not significant. It can
decrease the oxygen consumption of the tissue, delay the adenosine triphosphate
(ATP) consumption when tissue is ischemia<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. The mild hypothermia can improve the organization of
ischemia hypoxia tolerance<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>, so
that the organization oxygen can achieve balance between supply and demand, maintain
each organ function. It reduces metabolic demand and high energy phosphate
utilization in the myocardium<sup>[<xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup>, it is advantageous to oxygen
uptake and utilization of the heart cells. At the same time, mild hypothermia can
avoid ventricular fibrillation which may be caused by deep hypothermia, and Bernard
et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> have discovered the
incidence of infection is not common in short term hypothermia treatment (12-36
hours), so we chose the mild hypothermia for 36 hours in this study.</p><p>Some studies have shown that mild hypothermia inhibits inflammation reaction, inhibit
the release and expression of TNF-alpha and ICAM-1, and protect the organ function.
In the hypothermia application process, it should be fully realized the side effect
as its influence on blood coagulation function and so on. But in our study, we did
not observe any complication of clinical relevance associated with mild hypothermia,
especially bleeding, thrombosis, arterial or pulmonary embolism and no adverse
haemodynamic events. Rodriguez et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> showed that, in the case of patients with chill, oxygen
consumption will increase by 45%. Frank et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> found that for patients with a history of myocardial
ischemia, chill increased the risk of myocardial infarction, so we should use
sedation and neuromuscular blockade to anti-shiver in the duration of
hypothermia.</p><p>The second major finding is that moderate hypothermia significantly improves
parameters of organ function in the patients with MODS after CPB surgery. Low
cardiac output syndrome (LCOS) is a predominant cause of the MODS after cardiac
surgery<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, meanwhile,
MODS may lead to cardiovascular dysfunction characterized by biventricular
dilatation, decreased ejection fraction and hypotension<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Then MODS may lead to form a vicious circle, and
make the condition worse. So, in order to treat the MODS after cardiac surgery,
correcting heart function effectively is the most important. Because of the
improvement of cardiac function, the perfusion of the other organs was improved and
the organ functions were improved further. As cardiac power output predicts
mortality during LCOS<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>, our
data indicate that the improvement to the patients with MODS after CPB surgery in
the hypothermia group may in part be related to improved cardiac performance. In a
situation of severely depressed left ventricle function, cooling may improve
systemic oxygen supply-demand balance not only by reducing demand but also by
increasing cardiac output via its positive inotropic effect<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. The positive inotropic effect of
hypothermia has been confirmed by Gotberg et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> using whole-animal models of cardiogenic shock.
The inotropic effect of hypothermia is associated with an effect at the level of
myofilaments<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>, without
causing changes in sarcoplasmatic calcium content or intracellular calcium
concentration<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>. This
implies that hypothermia can recruit a contractile reserve without increasing energy
demand. In the acute myocardial infarction model, therapeutic hypothermia has been
proved that it improves myocardial dysfunction by reducing ischemia-reperfusion
injury and results in a decreased size of infarction<sup>[<xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref>]</sup>.
Ristagno et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup> studied the
effect of hypothermia on ventricular myocyte contractility, and discovered that
hypothermia increased ventricular myocyte contractility either under conditions of
normal perfusion or after perfusion following a 10 min interval of ischemia.
Shattock &#x00026; Bers<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> and Miao
&#x00026; Lynch<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> showed that
hypothermia increases in myocardial force generation and this was confirmed by
Fukunami &#x00026; Hearse<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup> and
Nishimura et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>. Suga et
al.<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup> resported that
cardiac cooling increased ventricular end-systolic maximum elastance (Emax) without
affecting systolic pressure-volume area (PVA)-independent VO<sub>2</sub> and has
energetically more advantages in saving myocardial oxygenconsumption compared to
catecholamine in cross circulated canine heart preparations.</p><p>Some limitations of our study should be acknowledged. Firstly, this study was
designed as a prospective unblended intervention trial, so there is a chance that
sicker patients might have been considered for normothermia. But in our study, the
initial parameters have no significant differences between the two groups. So the
authors think the potential bias induced by that is limited. Another limitation is
the information on temperature. We recorded the time in which TH was reached, but we
didn't document the course of the temperature during rewarming. Thus, maybe further
research is needed to identify the effect of the course of rewarming on
mortality.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In summary, our studies demonstrate that mild hypothermia is feasible and safe also
for patients with MODS after CPB surgery. Mild hypothermia can improve the organ
function effectively, and improve the morbidity and mortality of the patients. It
can slow the MODS/Systemic inflammatory response syndrome (SIRS) development speed
and reduce the time of protection and further treatment for cells and organs.</p><p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">XZ</td><td rowspan="1" colspan="1">Final manuscript approval</td></tr><tr><td rowspan="1" colspan="1">TG</td><td rowspan="1" colspan="1">Conception and design study; final manuscript approval</td></tr><tr><td rowspan="1" colspan="1">ZX</td><td rowspan="1" colspan="1">Statistical analysis; final manuscript approval</td></tr><tr><td rowspan="1" colspan="1">ES</td><td rowspan="1" colspan="1">Manuscript redaction or critical review of its content; final
manuscript approval</td></tr><tr><td rowspan="1" colspan="1">LY</td><td rowspan="1" colspan="1">Statistical analysis; final manuscript approval</td></tr></tbody></table></table-wrap>
</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out in the Department of Cardiac Surgery ICU, The First
Affiliated Hospital of China Medical University, Shenyang, P.R. China.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><article-title>American College of Chest Physicians/Society of Critical Care
Medicine Consensus Conference: definition for sepsis and organ failure and
guidelines for the use of innovative therapies in sepsis</article-title><source>Crit Care Med</source><year>1992</year><volume>20</volume><issue>6</issue><fpage>864</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">1597042</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umegaki</surname><given-names>T</given-names></name><name><surname>Ikai</surname><given-names>H</given-names></name><name><surname>Imanaka</surname><given-names>Y</given-names></name></person-group><article-title>The impact of acute organ dysfunction on patients' mortality with
severe sepsis</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2011</year><volume>27</volume><issue>2</issue><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">21772676</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thygesen</surname><given-names>K</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Simoons</surname><given-names>ML</given-names></name><name><surname>Chaitman</surname><given-names>BR</given-names></name><name><surname>White</surname><given-names>HD</given-names></name><collab>Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of
Myocardial Infarction</collab><collab>Authors/Task Force Members Chairpersons</collab><collab>ECG Subcommittee.Imaging Subcommittee</collab><collab>Classification Subcommittee</collab><collab>Intervention Subcommittee</collab><collab>Trials &#x00026; Registries Subcommittee</collab><collab>ESC Committee for Practice Guidelines</collab></person-group><article-title>Third universal definition of myocardial
infarction</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><issue>16</issue><fpage>1581</fpage><lpage>1598</lpage><pub-id pub-id-type="pmid">22958960</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuwen</surname><given-names>Z</given-names></name><name><surname>Chao</surname><given-names>W</given-names></name></person-group><article-title>Multi-center studies about the criterion of MODS</article-title><source>Chin J Surg</source><year>2009</year><volume>47</volume><issue>1</issue><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">19484949</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Hypothermia after Cardiac Arrest Study Group</collab></person-group><article-title>Mild therapeutic hypothermia to improve the neurologic outcome
after cardiac arrest</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>8</issue><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">11856793</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterbur</surname><given-names>K</given-names></name><name><surname>Mann</surname><given-names>FA</given-names></name><name><surname>Kuroki</surname><given-names>K</given-names></name><name><surname>DeClue</surname><given-names>A</given-names></name></person-group><article-title>Multiple organ dysfunction syndrome in humans and
animals</article-title><source>J Vet Intern Med</source><year>2014</year><volume>28</volume><issue>4</issue><fpage>1141</fpage><lpage>1151</lpage><pub-id pub-id-type="pmid">24773159</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khadaroo</surname><given-names>RG</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name></person-group><article-title>ARDS and the multiple organ dysfunction syndrome. Common
mechanisms of a common systemic process</article-title><source>Crit Care Clin</source><year>2002</year><volume>18</volume><issue>1</issue><fpage>127</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">11910726</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morariu</surname><given-names>AM</given-names></name><name><surname>Loef</surname><given-names>BG</given-names></name><name><surname>Aarts</surname><given-names>LP</given-names></name><name><surname>Rietman</surname><given-names>GW</given-names></name><name><surname>Rakhorst</surname><given-names>G</given-names></name><name><surname>van Oeveren</surname><given-names>W</given-names></name><etal/></person-group><article-title>Dexamethasone: benefit and prejudice for patients undergoing
on-pump coronary artery bypass grafting: a study on myocardial, pulmonary,
renal, intestinal, and hepatic injury</article-title><source>Chest</source><year>2005</year><volume>128</volume><issue>4</issue><fpage>2677</fpage><lpage>2687</lpage><pub-id pub-id-type="pmid">16236942</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sablotzki</surname><given-names>A</given-names></name><name><surname>Friedrich</surname><given-names>I</given-names></name><name><surname>M&#x000fc;hling</surname><given-names>J</given-names></name><name><surname>Dehne</surname><given-names>MG</given-names></name><name><surname>Spillner</surname><given-names>J</given-names></name><name><surname>Silber</surname><given-names>RE</given-names></name><etal/></person-group><article-title>The systemic inflammatory response syndrome following cardiac
surgery: different expression of proinflammatory cytokines and procalcitonin
in patients with and without multiorgan dysfunctions</article-title><source>Perfusion</source><year>2002</year><volume>17</volume><issue>2</issue><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">11958300</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tissier</surname><given-names>R</given-names></name><name><surname>Chenoune</surname><given-names>M</given-names></name><name><surname>Ghaleh</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>MV</given-names></name><name><surname>Downey</surname><given-names>JM</given-names></name><name><surname>Berdeaux</surname><given-names>A</given-names></name></person-group><article-title>The small chill: mild hypothermia for
cardioprotection?</article-title><source>Cardiovasc Res</source><year>2010</year><volume>88</volume><issue>3</issue><fpage>406</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">20621922</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birdi</surname><given-names>I</given-names></name><name><surname>Caputo</surname><given-names>M</given-names></name><name><surname>Underwood</surname><given-names>M</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name><name><surname>Bryan</surname><given-names>AJ</given-names></name></person-group><article-title>Influence of normothermic systemic perfusion temperature on cold
myocardial protection during coronary artery bypass surgery</article-title><source>Cardiovasc Surg</source><year>1999</year><volume>7</volume><issue>3</issue><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">10386759</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>ME</given-names></name><name><surname>Al-Khalidi</surname><given-names>AH</given-names></name><name><surname>Townend</surname><given-names>JN</given-names></name><name><surname>Coote</surname><given-names>J</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name></person-group><article-title>The effects of hypothermia on human left ventricular contractile
function during cardiac surgery</article-title><source>J Am Coll Cardiol</source><year>2002</year><volume>39</volume><issue>1</issue><fpage>102</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">11755294</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>NF</given-names></name><name><surname>Meyer</surname><given-names>PE</given-names></name><name><surname>Tauriainen</surname><given-names>MP</given-names></name><name><surname>Chao</surname><given-names>RY</given-names></name><name><surname>Patel</surname><given-names>JB</given-names></name><name><surname>Malloy</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Effects of hypothermia on myocardial substrate
selection</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><issue>4</issue><fpage>1208</fpage><lpage>1212</lpage><pub-id pub-id-type="pmid">12400770</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckberg</surname><given-names>GD</given-names></name><name><surname>Brazier</surname><given-names>JR</given-names></name><name><surname>Nelson</surname><given-names>RL</given-names></name><name><surname>Goldstein</surname><given-names>SM</given-names></name><name><surname>McConnell</surname><given-names>DH</given-names></name><name><surname>Cooper</surname><given-names>N</given-names></name></person-group><article-title>Studies of the effects of hypothermia on reginal myocardial blood
flow and metabolism during cardiopulmonary bypass-I. The adequately perfused
beating, fibrillating, and arrested heart</article-title><source>J Thorac Cardiovasc Surg</source><year>1977</year><volume>73</volume><issue>1</issue><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">831012</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>XH</given-names></name><name><surname>Xu</surname><given-names>CS</given-names></name><name><surname>Portman</surname><given-names>MA</given-names></name></person-group><article-title>Mitochondrial protein and HSP70 signaling after ischemia in
hypothermic-adapted hearts augmented with glucose</article-title><source>Am J Physiol</source><year>1999</year><volume>277</volume><issue>1</issue><issue-part>Pt 2</issue-part><fpage>R11</fpage><lpage>R17</lpage><pub-id pub-id-type="pmid">10409252</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>SA</given-names></name><name><surname>Gray</surname><given-names>TW</given-names></name><name><surname>Buist</surname><given-names>MD</given-names></name><name><surname>Jones</surname><given-names>BM</given-names></name><name><surname>Silvester</surname><given-names>W</given-names></name><name><surname>Gutteridge</surname><given-names>G</given-names></name><etal/></person-group><article-title>Treatment of comatose survivors of out-of-hospital cardiac arrest
with induced hypothermia</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>8</issue><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">11856794</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>JL</given-names></name><name><surname>Weissman</surname><given-names>C</given-names></name><name><surname>Damask</surname><given-names>MC</given-names></name><name><surname>Askanazi</surname><given-names>J</given-names></name><name><surname>Hyman</surname><given-names>AI</given-names></name><name><surname>Kinney</surname><given-names>JM</given-names></name></person-group><article-title>Physiologic requirements during rewarming: suppression of the
shivering response</article-title><source>Crit Care Med</source><year>1983</year><volume>11</volume><issue>7</issue><fpage>490</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">6407803</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>SM</given-names></name><name><surname>Fleisher</surname><given-names>LA</given-names></name><name><surname>Breslow</surname><given-names>MJ</given-names></name><name><surname>Higgins</surname><given-names>MS</given-names></name><name><surname>Olson</surname><given-names>KF</given-names></name><name><surname>Kelly</surname><given-names>S</given-names></name><etal/></person-group><article-title>Perioperative maintenance of normothermia reduces the incidence
of morbid cardiac events. A randomized clinical trial</article-title><source>JAMA</source><year>1997</year><volume>277</volume><issue>14</issue><fpage>1127</fpage><lpage>1134</lpage><pub-id pub-id-type="pmid">9087467</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>RH</given-names></name><name><surname>Zacharias</surname><given-names>A</given-names></name><name><surname>Schwann</surname><given-names>TA</given-names></name><name><surname>Riordan</surname><given-names>CJ</given-names></name><name><surname>Durham</surname><given-names>SJ</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name></person-group><article-title>Adverse effects of low hematocrit during cardiopulmonary bypass
in the adult: should current practice be changed?</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>125</volume><issue>6</issue><fpage>1438</fpage><lpage>1450</lpage><pub-id pub-id-type="pmid">12830066</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoesel</surname><given-names>LM</given-names></name><name><surname>Niederbichler</surname><given-names>AD</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name></person-group><article-title>Complement-related molecular events in sepsis leading to heart
failure</article-title><source>Mol Immunol</source><year>2007</year><volume>44</volume><issue>1-3</issue><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">16875736</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>LB</given-names></name></person-group><article-title>Cardiac pumping capability and prognosis in heart
failure</article-title><source>Lancet</source><year>1986</year><volume>2</volume><issue>8520</issue><fpage>328:1360</fpage><lpage>328:1363</lpage><pub-id pub-id-type="pmid">2874336</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessio</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Michael</surname><given-names>S</given-names></name><name><surname>Birgit</surname><given-names>Z</given-names></name><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Jochen</surname><given-names>V</given-names></name><etal/></person-group><article-title>Inotropic effects of experimental hyperthermia and hypothermia on
left ventricular function in pigs-comparison with dobutamine</article-title><source>Crit Care Med</source><year>2016</year><volume>44</volume><issue>3</issue><fpage>e158</fpage><lpage>e167</lpage><pub-id pub-id-type="pmid">26474110</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f6;tberg</surname><given-names>M</given-names></name><name><surname>van der Pals</surname><given-names>J</given-names></name><name><surname>Olivecrona</surname><given-names>GK</given-names></name><name><surname>G&#x000f6;tberg</surname><given-names>M</given-names></name><name><surname>Koul</surname><given-names>S</given-names></name><name><surname>Erlinge</surname><given-names>D</given-names></name></person-group><article-title>Mild hypothermia reduces acute mortality and improves hemodynamic
outcome in a cardiogenic shock pig model</article-title><source>Resuscitation</source><year>2010</year><volume>81</volume><issue>9</issue><fpage>1190</fpage><lpage>1196</lpage><pub-id pub-id-type="pmid">20627520</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusuoka</surname><given-names>H</given-names></name><name><surname>Ikoma</surname><given-names>Y</given-names></name><name><surname>Futaki</surname><given-names>S</given-names></name><name><surname>Suga</surname><given-names>H</given-names></name><name><surname>Kitabatake</surname><given-names>A</given-names></name><name><surname>Kamada</surname><given-names>T</given-names></name><etal/></person-group><article-title>Positive inotropism in hypothermia partially depends on an
increase in maximal Ca(2+)-activated force</article-title><source>Am J Physiol</source><year>1991</year><volume>261</volume><issue>4</issue><issue-part>Pt 2</issue-part><fpage>H1005</fpage><lpage>H1010</lpage><pub-id pub-id-type="pmid">1928384</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisser</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Bisping</surname><given-names>E</given-names></name><name><surname>Maier</surname><given-names>LS</given-names></name><name><surname>Beyersdorf</surname><given-names>F</given-names></name><name><surname>Hasenfuss</surname><given-names>G</given-names></name><etal/></person-group><article-title>Influence of mild hypothermia on myocardial contractivity and
circulatory function</article-title><source>Basic Res Cardiol</source><year>2001</year><volume>96</volume><issue>2</issue><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">11327339</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Hypothermia after Cardiac Arrest Study Group</collab></person-group><article-title>Mild therapeutic hypothermia to improve the neurologic outcome
after cardiac arrest</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>8</issue><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">11856793</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>SA</given-names></name><name><surname>Gray</surname><given-names>TW</given-names></name><name><surname>Buist</surname><given-names>MD</given-names></name><name><surname>Jones</surname><given-names>BM</given-names></name><name><surname>Silvester</surname><given-names>W</given-names></name><name><surname>Gutteridge</surname><given-names>G</given-names></name><etal/></person-group><article-title>Treatment of comatose survivors of out-of-hospital cardiac arrest
with induced hypothermia</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>8</issue><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">11856794</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristagno</surname><given-names>G</given-names></name><name><surname>Tantillo</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Weil</surname><given-names>MH</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name></person-group><article-title>Hypothermia improves ventricular myocyte contractility under
conditions of normal perfusion and after an interval of
ischemia</article-title><source>Resuscitation</source><year>2010</year><volume>81</volume><issue>7</issue><fpage>898</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">20395031</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shattock</surname><given-names>MS</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><article-title>Inotropic response to hypothermia and temperature-dependence of
ryanodine action in isolated rabbit and rat ventricular muscle: implications
for excitation-contraction coupling</article-title><source>Circ Res</source><year>1987</year><volume>61</volume><issue>6</issue><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">3677335</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>N</given-names></name><name><surname>Lynch</surname><given-names>C</given-names><suffix>3rd</suffix></name></person-group><article-title>Effect of temperature on volatile anesthetic depression of
myocardiac contractions</article-title><source>Anesth Analg</source><year>1993</year><volume>76</volume><issue>2</issue><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">8424518</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukunami</surname><given-names>M</given-names></name><name><surname>Hearse</surname><given-names>DJ</given-names></name></person-group><article-title>The intropic consequences of cooling: studies in the isolated rat
heart</article-title><source>Heart Vessels</source><year>1989</year><volume>5</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2584174</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Nishioka</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>Y</given-names></name></person-group><article-title>The effects of cardiac cooling under surface-induced hypothermia
on the cardiac function in the in situ heart</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2005</year><volume>4</volume><issue>2</issue><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">17670366</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Igarashi</surname><given-names>Y</given-names></name><name><surname>Yasumura</surname><given-names>Y</given-names></name><name><surname>Nozawa</surname><given-names>T</given-names></name><name><surname>Futaki</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cardiac cooling increases Emax without affecting relation between
O2 consumption and systolic pressure-volume area in dog left
ventricle</article-title><source>Circ Res</source><year>1998</year><volume>63</volume><issue>1</issue><fpage>61</fpage><lpage>71</lpage></element-citation></ref></ref-list></back></article>